Vimarsana
Biggest News Aggregation in the World

Page 3 - Eric Rojas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Rojas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Rojas Today - Breaking & Trending Today

Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Trea - Vimarsana News

Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Trea

– Data from multiple ongoing clinical studies of STK-001 show reductions in convulsive seizure frequency and improvements in cognition and behavior in children and adolescents with Dravet syndrome –– Data support the potential for STK-001 to be the first disease-modifying treatment for Dravet syndrome –– New pharmac...

50 Best Spanish-language Rappers of All Time – Billboard - Vimarsana News

50 Best Spanish-language Rappers of All Time – Billboard

50 Greatest Spanish-language Rappers of All Time

Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 - Vimarsana News

Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001

– Totality of data from these ongoing studies suggest clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Phase 1/2a ADMIRAL Study Data STK-001 (70mg): Patients treated with 2 or 3 ini...

No one knew Boilermaker would become a very big deal - Vimarsana News

No one knew Boilermaker would become a very big deal

No one had any idea what this might turn into. The very first Boilermaker Road Race was a nice thing, of course, a product of the running boom of the early 1970s.

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Vimarsana News

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that, effective on June 15, 2023, the company granted stock options to purchas...